Arena Shares Fall After FDA Document Raises Lorcaserin Safety Issues


Published On: September 15th, 2010

The FDA’s briefing document raised the issue of increased rates of malignant tumors in rodents taking high doses of the diet drug lorcaserin.

See the original post: 
Arena Shares Fall After FDA Document Raises Lorcaserin Safety Issues



Loading...


Comments are closed.